Pioglitazone and lung cancer risk in Taiwanese patients with type 2 diabetes.
Pioglitazone and lung cancer risk in Taiwanese patients with type 2 diabetes.
Diabetes Metab. 2017 Jul 03;:
Authors: Tseng CH
PMID: 28684163 [PubMed - as supplied by publisher]
Source: Diabetes and Metabolism - Category: Endocrinology Authors: Tseng CH Tags: Diabetes Metab Source Type: research
More News: Actos | Cancer | Cancer & Oncology | Diabetes | Diabetes Type 2 | Endocrinology | Lung Cancer | Taiwan Health